Wockhardt share news, announcements and annual reports
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Wockhardt Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000
Last close ₹1,901.10down ₹21.80 (1.13%)BSE ₹1,896.10
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,922.90.
30 Oct: open ₹1,923.00, high ₹1,932.90, low ₹1,872.00
52-week range of traded prices to 30 Oct 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30,891 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 75.53
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.25
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,06,69638.4% delivered
Wockhardt orders, deals and press releases
216 filed, newest first. Page 4 of 5.
Aug 2012
Apr 2012
Jan 2012
Jul 2011
Jun 2011
May 2011
5 May · Business
Hon'ble High Court of Delhi has approved the Scheme of Arrangement under Section 391 to 394 of the Companies Act, 1956 in the nature of Demerger of Nutrition business of Vinton Healthcare Limited, a wholly owned subsidiary of the Company into Wockhardt Limited ("the Company") with effect from the appointed date i.e. January 01, 2011.
Apr 2011
Mar 2011
Jan 2011
12 Jan · Business
Board of Directors of the Company at their meeting held on January 12, 2011 have considered and approved Scheme of Arrangement under Section 391 to 394 of the Companies Act, 1956 in the nature of Demerger of Nutrition business of the Vinton Healthcare Limited, a wholly owned subsidiary of the Company into Wockhardt Limited ("the Company") with effect from the appointed date January 1, 2011. As Vinton Healthcare Limited is a wholly owned subsidiary of the Company, no shares would be issued by the Company pursuant to the aforesaid Scheme of Demerger. The said scheme of Arrangement in the nature of Demerger shall be subject to the approval of shareholders of the Vinton Healthcare Limited ("Demerged Company"), the approval of Jurisdictional High Court in which Demerged Company is situated and requisite consent and approval of the statutory and regulatory authorities as may be required for the implementation of the scheme.
Oct 2010
Jul 2010
May 2010
Apr 2010
28 Apr · Business
Press release dated April 28, 2010, titled "Wockhardt launches Prostate drug Flomax in the United States on Day-1". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Apr · Business
Press release dated April 01, 2010, titled "Wockhardt and Abbott jointly terminate the Nutrition business deal". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
13 Jan · Business
Press release dated January 13, 2010, titled "Wockhardt receives US FDA approval for antibacterial Levofloxacin". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Jan · Business
Press release dated January 06, 2010, titled "Wockhardt receives US FDA approval for Alzheimer's drug Memantine". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2009
18 Nov · Business
Press release dated November 18, 2009, titled "Wockhardt launches anti-hypertensive drug Nicardipine injections in USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
1 Oct · Business
Press release dated October 01, 2009, titled "Wockhardt receives US FDA approval for Prostate drug Alfuzosin tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
29 Sep · Business
Press release dated September 29, 2009, titled "Wockhardt receives US FDA approval for Prostate drug Tamsulosin capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Sep · Business
Press release dated September 24, 2009, titled "Wockhardt wins Government of India Patent Award; 70 Patents Granted: 15 Indian and 55 International". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
20 Aug · Business
Press release dated August 20, 2009, titled "Wockhardt divests its Veterinary business to Vetoquinol". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
28 Jul · Business
Press release dated July 28, 2009, titled "Wockhardt signs agreements to divest its Nutrition businesses to Abbott". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
29 Jun · Business
Press release dated June 27, 2009, titled "Wockhardt signs agreement to divest its Animal Health Division". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
29 May · Business
Press release dated May 29, 2009, titled "Wockhardt appoints BDO Haribhakti as auditor". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
29 Apr · Business
Press release dated April 29, 2009, titled "Wockhardt announces Entacapone patent settlement with Orion Corporation". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Apr · Business
Press release dated April 24, 2009, titled "Consolidated sales grew by 35.4% to Rs. 3,593 crores Operating Profits (EBITDA) grew by 26.5% to Rs. 808 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Apr · Business
Press release dated April 01, 2009, titled "Wockhardt announces its succession plan under the leadership of Chairman Habil Khorakiwala: Dr. Murtaza Khorakiwala is Managing Director, Huzaifa Khorakiwala is Executive Director". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
26 Feb · Business
Press release dated February 26, 2009, titled "Wockhardt to launch generic version of ulcer drug Ranitidine syrup in the US market". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Feb · Business
Press release dated February 17, 2009, titled "Wockhardt to launch generic version of migraine drug Sumatriptan in the US market". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Feb · Business
Press release dated February 12, 2009, titled "Wockhardt to launch Leveiracetam, a generic version of epilepsy drug in the US market". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Feb · Business
Press release dated February 11, 2009, titled "Wockhardt to launch Divalproex ER in the US market; Gets US FDA approval for generic version of epilepsy drug". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Feb · Business
Press release dated February 10, 2009 titled "A biotechnology breakthrough in Diabetes; Wockhardt launches new insulin (Glaritus) in India; First in the world after innovator". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
14 Jan · Business
Press release dated January 14, 2009, titled "Wockhardt signs in-licensing agreement with a Swiss firm for Bonistein; In-licensing deal to market Bonistein, a patented product, specially designed for Osteoporosis". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2008
4 Dec · Business
Press release dated December 04, 2008, titled "Wockhardt receives US FDA approval for generic version of Augmentin* Suspension". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
14 Nov · Business
Press release dated November 13, 2008, titled "Wockhardt Launches Midazolam in the US Market, Gets US FDA approval for generic version of insomnia drug". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
16 Oct · Business
Press release dated October 16, 2008, titled "Wockhardt gets US FDA nod to market Ceftazidime injections". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Oct · Business
Press release dated October 08, 2008, titled "Wockhardt takes huge strides towards In-licensing and collaborative agreements - Signs in-licensing deal with UK based Sinclair Pharma". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2008
24 Mar · Business
Press release dated March 20, 2008, titled "No impact of derivatives on Wockhardt". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
13 Feb · Business
Press release dated February 12, 2008, titled "Wockhardt enters the US market with Zithromax". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
9 Jan · Business
Press release dated January 09, 2008, titled "Wockhardt to launch generic version of anti-depressant Zoloft in the US market". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Jan · Business
Press release dated January 01, 2008, titled "Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
24 Oct · Business
Press release dated October 24, 2007, titled "Wockhardt acquires Morton Grove in the US". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Oct · Business
Press release dated October 17, 2007, titled "Wockhardt to market SAMMY-a patented process tablet for Osteoarthritis". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.